Background: HIV assays designed to detect recent infection, also known as “recency
assays,” are often used to estimate HIV incidence in a specific country, region, or …

Introduction The need for detection of new and recent HIV infections is essential for
surveillance and assessing interventions in controlling the epidemic. HIV recency assays …

Introduction Cross‐sectional incidence testing is used to estimate population‐level HIV
incidence and measure the impact of prevention interventions. There are limited data …

Background HIV-1 molecular epidemiology amongst men who have sex with men (MSM) in
sub-Saharan Africa remains not well characterized. We aimed to determine HIV-1 subtype …

Introduction: high HIV-1 infection rates and genetic diversity especially in African population
pose significant challenges in HIV-1 clinical management and drug design and …

Background Recent infection testing algorithms (RITAs) incorporating clinical information
with the HIV recency assay have been proven to accurately classify recent infection …

Monitoring genetic diversity and recent HIV infections (RHIs) is critical for understanding HIV
epidemiology. Here, we report HIV-1 genetic diversity and RHIs in blood samples from 190 …

Background Assays and multi-assay algorithms (MAAs) have been developed for population-
level cross-sectional HIV incidence estimation. These algorithms use a combination of …

Nationally representative surveys provide an opportunity to assess trends in recent human
immunodeficiency virus (HIV) infection based on assays for recent HIV infection. We …

Recency assays use one or more biomarkers to identify whether HIV infection in a person is
recent (usually within a year or less) or longstanding. Recency assays have been used to …